Senior Director
Johnson and Johnson
Navin Goyal is currently a Senior Director and Therapy Area Group Lead in the Clinical Pharmacology and Pharmacometrics (CPP) Group at Johnson and Johnson Innovative Medicines, supporting the cardiovascular, metabolism, retinal, pulmonary hypertension, and neuroscience therapy areas. In this role, he is responsible for applying clinical pharmacology principles and model-based approaches across all phases of drug discovery and development spanning from early clinical studies through registration. He graduated from the Department of Pharmaceutics in College of Pharmacy at University of Florida, Gainesville. He has published and presented his work across multiple therapy areas including respiratory, neuroscience, cardiovascular and infectious diseases. His research interests also include pediatric drug development and new modalities. In addition to the day job, he continues to mentor student interns, post-doctoral fellows and scientists within his group at JnJ and through external collaborations. He currently also serves on the ACCP Board of Regents.
Disclosure(s): Johnson and Johnson: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Revolutionizing the Clinical Research for Long-Acting Injectables: What to Expect Globally?
Friday, March 29, 2024
3:00 PM – 4:00 PM MDT